170 related articles for article (PubMed ID: 31377702)
1. Tablet-based sensorimotor home-training system for amnestic mild cognitive impairments in the elderly: design of a randomised clinical trial.
Bekrater-Bodmann R; Löffler A; Silvoni S; Frölich L; Hausner L; Desch S; Kleinböhl D; Flor H
BMJ Open; 2019 Aug; 9(8):e028632. PubMed ID: 31377702
[TBL] [Abstract][Full Text] [Related]
2. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).
Li D; Mielke MM; Bell WR; Reilly C; Zhang L; Lin FV; Yu F
Trials; 2020 Jan; 21(1):19. PubMed ID: 31907024
[TBL] [Abstract][Full Text] [Related]
3. Effect of cognitive training on episodic memory retrieval in amnestic mild cognitive impairment patients: study protocol for a clinical randomized controlled trial.
Zhang K; Wang J; Peng G; Liu P; He F; Zhu Z; Luo B
Trials; 2019 Jan; 20(1):26. PubMed ID: 30621794
[TBL] [Abstract][Full Text] [Related]
4. Cognitive training and neuroplasticity in mild cognitive impairment (COG-IT): protocol for a two-site, blinded, randomised, controlled treatment trial.
D'Antonio J; Simon-Pearson L; Goldberg T; Sneed JR; Rushia S; Kerner N; Andrews H; Hellegers C; Tolbert S; Perea E; Petrella J; Doraiswamy PM; Devanand D
BMJ Open; 2019 Aug; 9(8):e028536. PubMed ID: 31471436
[TBL] [Abstract][Full Text] [Related]
5. Ageing stereotypes and prodromal Alzheimer's disease (AGING): study protocol for an ongoing randomised clinical study.
Gauthier K; Morand A; Dutheil F; Alescio-Lautier B; Boucraut J; Clarys D; Eustache F; Girard N; Guedj E; Mazerolle M; Paccalin M; de la Sayette V; Zaréa A; Huguet P; Michel BF; Desgranges B; ; Régner I
BMJ Open; 2019 Oct; 9(10):e032265. PubMed ID: 31594904
[TBL] [Abstract][Full Text] [Related]
6. White matter integrity disruption in the pre-dementia stages of Alzheimer's disease: from subjective memory impairment to amnestic mild cognitive impairment.
Shao W; Li X; Zhang J; Yang C; Tao W; Zhang S; Zhang Z; Peng D
Eur J Neurol; 2019 May; 26(5):800-807. PubMed ID: 30584694
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the fine motor problems in patients with cognitive dysfunction - A computerized handwriting analysis.
Yu NY; Chang SH
Hum Mov Sci; 2019 Jun; 65():. PubMed ID: 29934222
[TBL] [Abstract][Full Text] [Related]
8. Effects of brain training on brain blood flow (The Cognition and Flow Study-CogFlowS): protocol for a feasibility randomised controlled trial of cognitive training in dementia.
Beishon L; Evley R; Panerai RB; Subramaniam H; Mukaetova-Ladinska E; Robinson T; Haunton V
BMJ Open; 2019 May; 9(5):e027817. PubMed ID: 31122994
[TBL] [Abstract][Full Text] [Related]
9. Association between plasma exosome neurogranin and brain structure in patients with Alzheimer's disease: a protocol study.
He M; Sun L; Cao W; Yin C; Sun W; Liu P; Tan L; Xu Z; Zhao W
BMJ Open; 2020 Aug; 10(8):e036990. PubMed ID: 32801201
[TBL] [Abstract][Full Text] [Related]
10. A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial.
Possemis N; Verhey F; Prickaerts J; Blokland A; Ramakers I
Trials; 2024 Mar; 25(1):162. PubMed ID: 38438923
[TBL] [Abstract][Full Text] [Related]
11. Saccade deficits in amnestic mild cognitive impairment resemble mild Alzheimer's disease.
Peltsch A; Hemraj A; Garcia A; Munoz DP
Eur J Neurosci; 2014 Jun; 39(11):2000-13. PubMed ID: 24890471
[TBL] [Abstract][Full Text] [Related]
12. Resting state functional connectivity abnormalities and delayed recall performance in patients with amnestic mild cognitive impairment.
Joshi H; Bharath S; John JP; Sadanand S; Saini J; Kumar K; Varghese M
Brain Imaging Behav; 2020 Feb; 14(1):267-277. PubMed ID: 30421086
[TBL] [Abstract][Full Text] [Related]
13. Using virtual reality to characterize episodic memory profiles in amnestic mild cognitive impairment and Alzheimer's disease: influence of active and passive encoding.
Plancher G; Tirard A; Gyselinck V; Nicolas S; Piolino P
Neuropsychologia; 2012 Apr; 50(5):592-602. PubMed ID: 22261400
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Memory Binding Distinguishing Amnestic Mild Cognitive Impairment from Healthy Aging: A Machine Learning Study.
Martínez-Florez JF; Osorio JD; Cediel JC; Rivas JC; Granados-Sánchez AM; López-Peláez J; Jaramillo T; Cardona JF
J Alzheimers Dis; 2021; 81(2):729-742. PubMed ID: 33814438
[TBL] [Abstract][Full Text] [Related]
15. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects between SMR/delta-ratio and beta1/theta-ratio neurofeedback training for older adults with Mild Cognitive Impairment: a protocol for a randomized controlled trial.
Marlats F; Djabelkhir-Jemmi L; Azabou E; Boubaya M; Pouwels S; Rigaud AS
Trials; 2019 Jan; 20(1):88. PubMed ID: 30696475
[TBL] [Abstract][Full Text] [Related]
17. Deficits in episodic memory retrieval reveal impaired default mode network connectivity in amnestic mild cognitive impairment.
Dunn CJ; Duffy SL; Hickie IB; Lagopoulos J; Lewis SJ; Naismith SL; Shine JM
Neuroimage Clin; 2014; 4():473-80. PubMed ID: 24634833
[TBL] [Abstract][Full Text] [Related]
18. Cognitive Training Using a Novel Memory Game on an iPad in Patients with Amnestic Mild Cognitive Impairment (aMCI).
Savulich G; Piercy T; Fox C; Suckling J; Rowe JB; O'Brien JT; Sahakian BJ
Int J Neuropsychopharmacol; 2017 Aug; 20(8):624-633. PubMed ID: 28898959
[TBL] [Abstract][Full Text] [Related]
19. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
[TBL] [Abstract][Full Text] [Related]
20. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.
Kelly SC; He B; Perez SE; Ginsberg SD; Mufson EJ; Counts SE
Acta Neuropathol Commun; 2017 Jan; 5(1):8. PubMed ID: 28109312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
